ORTHOFIX MEDICAL INC.
OFIX Healthcare Medical Devices
ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024. In the quarter to June 2026, revenue grew 3.85%, EPS fell 8.33%, free cash flow fell 516.6% and total debt rose 34.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow OFIX
ORTHOFIX MEDICAL INC. (OFIX) P/E ratio
ORTHOFIX MEDICAL INC. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 789× (December 2017) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 331× | — |
| FY2019 | 0.0× | — |
| FY2018 | 71.9× | (55.18%) |
| FY2017 | 160× | (23.25%) |
| FY2016 | 209× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SI Shoulder Innovations, Inc. compare | n/m |
| SENS Senseonics Holdings, Inc. compare | n/m |
| OFIX ORTHOFIX MEDICAL INC. | n/m |
| CERS Cerus Corporation compare | n/m |
| NPCE NeuroPace, Inc. compare | n/m |
| RCEL Avita Medical Inc. compare | n/m |
| CV CapsoVision, Inc. compare | 2.1× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 24.8× |
| VMD Viemed Healthcare, Inc. compare | 24.9× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)